Andrew Allan Almonte
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 14, 2026
Gut dysbiosis in oncology: a risk factor for immunoresistance.Andrew Allan Almonte, Simon Thomas, Valerio Iebba
|Apr 30, 2025
Oncobiomics: Leveraging Microbiome Translational Research in Immuno-Oncology for Clinical-Practice Changes.Carolina Alves Costa Silva, Andrew A Almonte, Laurence Zitvogel
|Apr 22, 2025
Microbiota-centered interventions to boost immune checkpoint blockade therapies.Andrew A Almonte, Simon Thomas, Laurence Zitvogel
|Nov 06, 2023
Early T Cell Infiltration Correlates with Anti-CTLA4 Treatment Response in Murine Cancer Models.Andrew A Almonte, George Cavic, Christina S E Carroll
|Nov 02, 2022
Gut microbiome-depleting antibiotic regimens are not tolerated by all mouse strains: learn from (our) bitter experience.Andrew A Almonte, George Cavic, Teresa Neeman
|Nov 04, 2020
How does the gut microbiome influence immune checkpoint blockade therapy?Andrew A Almonte, Hareesha Rangarajan, Desmond Yip
Pageof 2
Frequent Collaborators
2 joint publications
George Cavic
2 joint publications
Teresa Neeman
2 joint publications
Aude M Fahrer
2 joint publications
Laurence Zitvogel
1 joint publications
Desmond Yip
1 joint publications
Anselm Enders
1 joint publications
Christina S E Carroll
1 joint publications
Simon Thomas
1 joint publications
Valerio Iebba
